Increasing Prevalence Of Infectious Diseases Driving The Market Growth Due To Antimicrobial Resistance Is Supporting Development Across The Rapid Diagnostic Test Kits Market

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Much Larger Will The Rapid Diagnostic Test Kits Market Become By 2030 Compared To 2026?

The rapid diagnostic test kits market has experienced robust expansion in recent years. Projections indicate a rise from $24.08 billion in 2025 to $25.59 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 6.3%. Historically, this expansion has been driven by factors such as the increasing burden of infectious diseases, the expansion of decentralized healthcare delivery, a rising demand for quick diagnostic results, the growth in outpatient and homecare testing, and the availability of lateral flow and immunoassay technologies.

The rapid diagnostic test kits market size is projected to experience substantial expansion in the coming years. This market is anticipated to reach $32.22 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.9%. The projected growth during this period stems from factors such as increased investments in rapid diagnostic innovation, the rising uptake of self-testing kits, the broadening of infectious disease surveillance initiatives, an escalating need for economical diagnostics in developing economies, and the growing incorporation of digital readout technologies. Key trends foreseen for the forecast period encompass a greater adoption of point-of-care testing solutions, an increased appetite for multiplex rapid test kits, more widespread use of diagnostics performed at home, the proliferation of portable and disposable test formats, and an intensified emphasis on identifying diseases early.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24678&type=smp

Which Growth Drivers Are Expected To Support The Rapid Diagnostic Test Kits Market Forward?

The rapid diagnostic test kits market is anticipated to experience growth due to the escalating prevalence of infectious diseases. These diseases are defined as illnesses caused by pathogenic microorganisms such as bacteria, viruses, fungi, or parasites, capable of spreading directly or indirectly between individuals. The rising occurrence of infectious diseases is fueled by antimicrobial resistance and the evolution of pathogen strains, as extensive antibiotic use has led to drug-resistant bacterial infections while viruses continue to mutate, creating new variants that evade existing immunity and necessitate updated detection methods. This increasing prevalence encourages the greater adoption of point-of-care testing devices, which enable prompt identification of pathogens. This allows healthcare providers to quickly diagnose infections, initiate appropriate treatment, and implement timely infection control measures. For instance, data from March 2024, provided by the Centers for Disease Control and Prevention, a US-based government agency, indicated that the number of tuberculosis cases rose from 8,320 in 2022 to 9,615 in 2023, representing an increase of 1,295 cases. Thus, the growing prevalence of infectious diseases is a significant driver for the rapid diagnostic test kits market’s expansion.

Which Segment Groups Define The Rapid Diagnostic Test Kits Market Landscape?

The rapid diagnostic test kits market covered in this report is segmented –

1) By Product Type: Antigen Test Kits, Antibody Test Kits, Nucleic Acid Test Kits, Multi-Analyte Test Kits

2) By Technology: Fluorescent Immunoassay, Enzyme-Linked Immunosorbent Assay (ELISA), Colloidal Gold-Based Test, Lateral Flow Assays

3) By Application: Infectious Disease Testing, Cardiology Testing, Oncology Testing, Pregnancy And Fertility Testing, Toxicology Testing, Glucose Monitoring, Other Applications

4) By End-User: Hospitals, Diagnostic Laboratories, Home Care Settings, Pharmacies

Subsegments:

1) By Antigen Test Kits: COVID-19 Antigen Test Kits, Influenza Antigen Test Kits, Malaria Antigen Test Kits, Respiratory Syncytial Virus Antigen Test Kits, Streptococcus Antigen Test Kits

2) By Antibody Test Kits: HIV Antibody Test Kits, Hepatitis Antibody Test Kits, COVID-19 Antibody Test Kits, Dengue Antibody Test Kits, Syphilis Antibody Test Kits

3) By Nucleic Acid Test Kits: HIV Nucleic Acid Test Kits, Hepatitis B And C Nucleic Acid Test Kits, Human Papillomavirus Nucleic Acid Test Kits, Tuberculosis Nucleic Acid Test Kits, COVID-19 Nucleic Acid Test Kits

4) By Multi-Analyte Test Kits: Respiratory Panel Test Kits, Sexually Transmitted Infections Panel Test Kits, Gastrointestinal Panel Test Kits, Febrile Illness Panel Test Kits, Sepsis Marker Panel Test Kits

What Trends Are Driving Changes In The Rapid Diagnostic Test Kits Market?

Key players in the radiotherapy induced oral mucositis treatment market are prioritizing the creation of advanced products, including low-level laser therapy, aimed at accelerating healing, diminishing pain, and boosting patient well-being throughout cancer therapy. Low-level laser therapy, also recognized as cold laser therapy or photobiomodulation, provides a non-invasive solution that employs low-power lasers or light-emitting diodes (LEDs) to stimulate recovery and lessen both pain and inflammation. An example of this trend is seen in October 2024, when Jaguar Health Inc., a US-based pharmaceuticals company, introduced gelclair, an oral mucositis prescription product. This product is precisely formulated to alleviate pain stemming from oral mucositis, a condition experienced by up to 90% of head and neck cancer patients undergoing chemotherapy and radiotherapy. Through its adherence to the mucosal lining of the mouth, gelclair offers prompt and prolonged pain relief without the stinging or numbing side effects frequently associated with other therapies.

Which Organizations Are Involved In The Rapid Diagnostic Test Kits Market?

Major companies operating in the rapid diagnostic test kits market are F Hoffmann La Roche Ltd, Thermo Fisher Scientific Inc, Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, Hologic Inc, bioMerieux SA, QuidelOrtho Corporation, Bio Rad Laboratories Inc, QIAGEN NV, Cepheid Inc, OraSure Technologies Inc, Nova Biomedical Corporation, Sekisui Diagnostics LLC, EKF Diagnostics Holdings plc, Trinity Biotech plc, ACON Laboratories Inc, Fluxergy LLC, Lumos Diagnostics Holdings Limited, Abingdon Health plc, Abionic SA

Access The Complete Rapid Diagnostic Test Kits Market Report:

https://www.thebusinessresearchcompany.com/report/rapid-diagnostic-test-kits-global-market-report

Which Region Accounts For The Highest Share Of The Rapid Diagnostic Test Kits Market?

North America was the largest region in the rapid diagnostic test kits market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rapid diagnostic test kits market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Rapid Diagnostic Test Kits Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=24678&type=smp

Browse Through More Reports Similar to the Global Rapid Diagnostic Test Kits Market 2026, By The Business Research Company

Single Dose Radiotherapy Services Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/single-dose-radiotherapy-services-global-market-report

Image Guided Radiation Therapy Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/image-guided-radiation-therapy-global-market-report

Medical Irradiation Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/medical-irradiation-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795